Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study

類似資料

• Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
  著者:: Gattorno, Marco, 等
  出版事項: (2017)
• OR10-006 - Canakinumab in patients with TRAPS
  著者:: Lachmann, HJ, 等
  出版事項: (2013)
• Long-term efficacy and safety of Canakinumab in active Hyper-IgD syndrome (HIDS): results from an open-label study
  著者:: Aróstegui, JI, 等
  出版事項: (2015)
• Gene expression profiling in understanding the molecular pathogenesis of and response to canakinumab therapy in traps
  著者:: Gattorno, M, 等
  出版事項: (2014)
• Pharmacokinetics of Canakinumab in children younger than 2 years old with CAPS
  著者:: Kalabus, J, 等
  出版事項: (2015)